Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,041 | 20,608 | 792 | 4,230 | 161 |
| Receivables | 323 | 434 | 357 | 696 | 777 |
| Inventories | 53 | 475 | 415 | N/A | N/A |
| Other current assets | 345 | 802 | 0 | 2,252 | 23,517 |
| TOTAL | $11,509 | $23,214 | $1,787 | $7,178 | $24,455 |
| Non-Current Assets | |||||
| PPE Net | 1,106 | 1,020 | 1,031 | 558 | 558 |
| Investments And Advances | 0 | 0 | 0 | 92 | 92 |
| Intangibles | 0 | 0 | 0 | 5,985 | 9,312 |
| Other Non-Current Assets | 2,590 | 13,402 | 1,231 | 1,091 | 989 |
| TOTAL | $3,696 | $14,422 | $2,262 | $7,726 | $10,951 |
| Total Assets | $15,205 | $37,636 | $4,049 | $14,904 | $35,406 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 2,481 |
| Accounts payable and accrued liabilities | 655 | 740 | 1,300 | 2,072 | 4,598 |
| Accrued Expenses | 1,154 | 764 | 162 | N/A | N/A |
| Other current liabilities | N/A | N/A | 9 | 916 | 621 |
| TOTAL | $3,665 | $5,431 | $2,049 | $6,972 | $28,148 |
| Non-Current Liabilities | |||||
| Long Term Debt | 57 | 57 | 6,839 | N/A | N/A |
| Deferred Revenues | 72 | 74 | 92 | 1,217 | 1,214 |
| Other Non-Current Liabilities | 1,301 | 565 | 31,601 | 440 | 248 |
| TOTAL | $1,631 | $915 | $38,440 | $547 | $456 |
| Total Liabilities | $5,296 | $6,346 | $40,489 | $7,519 | $28,604 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,268 | 5,800 | 2,201 | 422 | 375 |
| Common Shares | 1 | 1 | N/A | N/A | N/A |
| Retained earnings | -101,503 | -78,813 | -37,954 | -164,424 | -157,716 |
| Other shareholders' equity | -32 | -74 | 0 | 26 | 60 |
| TOTAL | $9,909 | $31,290 | $-36,440 | $7,385 | $6,802 |
| Total Liabilities And Equity | $15,205 | $37,636 | $4,049 | $14,904 | $35,406 |